Current issue

October 2016

Volume 54

Issue 10

Welcome to Drug and Therapeutics Bulletin (DTB)

For 50 years, Drug and Therapeutics Bulletin (DTB) has provided rigorous and independent evaluations of, and practical advice on, individual treatments and the overall management of disease for doctors, pharmacists and other healthcare professionals.

DTB has always been wholly independent of the pharmaceutical industry, Government and regulatory authorities. DTB is also free of advertising and other forms of commercial sponsorship.

Nalmefene - time for last orders?

Evidence of clinical and cost effectiveness of nalmefene is far too weak; DTB questions how the cost of the drug can be justified in such a cash-strapped era for the NHS.

Read the article  >>

DTB podcasts

Listen to the latest DTB podcast, with Editor in Chief James Cave and Deputy Editor David Phizackerley discussing this month's issue:

Listen to the latest podcast >>
Previous podcasts >>

Free sample issue

This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of DTB: now:

View free sample issue >>

Sign up for eTOC alerts >>

Suggest a Topic

Do you want to get involved in producing content for DTB and helping to set the standard for prescribing practice in the UK and around the world?

Find out more >>

DTB education

Read educational articles published in DTB and then test your knowledge on BMJ Learning:

Test your knowledge >>

Follow DTB

Keep up to date with the latest news and content from the journal.

Twitter >>


Email Alerts >>